Differentiating vasculitis from other diseases: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 192: | Line 192: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bleeding]], [[Easy bruising|Bruisability]], [[Heart murmur]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bleeding]], [[Easy bruising|Bruisability]], [[Heart murmur]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]]<ref name="pmid18390527">{{cite journal| author=Michet CJ, Matteson EL| title=Polymyalgia rheumatica. | journal=BMJ | year= 2008 | volume= 336 | issue= 7647 | pages= 765-9 | pmid=18390527 | doi=10.1136/bmj.39514.653588.80 | pmc=2287267 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18390527 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 201: | Line 201: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fibrinogen|Plasma fibrinogen]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normocytic normochromic anemia|Normocytic, normochromic anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CRP]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Odontoid process|Periodontoid]] localization of [[calcification]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vessel wall]] thickening, Increased mural contrast enhancement | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Subacromial bursitis|Subacromial]] or subdeltoid [[bursitis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |High [[Fluorescein sodium|F-FDG]] accumulation around the [[joints]] in [[Positron emission tomography|FDG PET-CT]] | ||
! | !Small angular fibers, [[Pyknosis|Pyknotic]] [[nuclear]] clumps, or target-targetoid fibers | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Joint stiffness]], [[Fatigue]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Joint stiffness]], [[Fatigue]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Amyloidosis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Amyloidosis]]<ref name="pmid23227278">{{cite journal| author=Baker KR, Rice L| title=The amyloidoses: clinical features, diagnosis and treatment. | journal=Methodist Debakey Cardiovasc J | year= 2012 | volume= 8 | issue= 3 | pages= 3-7 | pmid=23227278 | doi= | pmc=3487569 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23227278 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 222: | Line 222: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Immunoglobulin light chains|Immunoglobulin light chain]][[Amyloid beta|(Amyloid)]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ↑ [[ALT]] or [[AST]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Diffusely hypoattenuating and enlarged [[liver]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Amyloid]] deposition in the media and [[adventitia]] of small arteries | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Solid organs increased [[echogenicity]] | ||
! | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Tc-DPD for [[cardiac]] '''[[amyloid]]''' deposits | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ![[Extracellular]] deposition of [[Fibrillarin|fibrillar proteins]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Biopsy]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cardiomegaly]], [[Dyspnea]] | |||
|- | |- | ||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ||
Line 257: | Line 258: | ||
! rowspan="18" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Medium-Vessel Vasculitis | ! rowspan="18" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Medium-Vessel Vasculitis | ||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polyarteritis nodosa]] | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polyarteritis nodosa]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[ESR]], [[CRP]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia]], [[Thrombocytosis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | ||
↑ [[ALT]] or [[AST]], [[Proteinuria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 278: | Line 280: | ||
|- | |- | ||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B virus]]-associated [[polyarteritis nodosa]] | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B virus]]-associated [[polyarteritis nodosa]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis B surface antigen|HBsAg]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia]], [[Thrombocytosis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[ALT]] or [[AST]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 299: | Line 301: | ||
|- | |- | ||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Kawasaki disease]] | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Kawasaki disease]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 317: | Line 319: | ||
! | ! | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Diarrhea]], [[Vomiting]] | ||
|- | |- | ||
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infectious disease]] | ! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infectious disease]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Parvovirus B19 infection]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Parvovirus B19 infection]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 342: | Line 344: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Scarlet fever]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Scarlet fever]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 363: | Line 365: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic shock syndrome]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic shock syndrome]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 384: | Line 386: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mononucleosis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mononucleosis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 405: | Line 407: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leptospirosis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leptospirosis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 426: | Line 428: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Lyme disease|Lyme Disease]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Lyme disease|Lyme Disease]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 447: | Line 449: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Measles]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Measles]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 468: | Line 470: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rocky Mountain Spotted Fever]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rocky Mountain Spotted Fever]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 489: | Line 491: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 510: | Line 512: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic Epidermal Necrolysis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic Epidermal Necrolysis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 532: | Line 534: | ||
! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular disease]] | ! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular disease]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Atrial Myxoma]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Atrial Myxoma]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 553: | Line 555: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholesterol Embolism]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholesterol Embolism]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 574: | Line 576: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Segmental arteries|Segmental arterial]] mediolysis | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Segmental arteries|Segmental arterial]] mediolysis | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 596: | Line 598: | ||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Antiphospholipid syndrome|Antiphospholipid Syndrome]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Antiphospholipid syndrome|Antiphospholipid Syndrome]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 617: | Line 619: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Juvenile Idiopathic Arthritis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Juvenile Idiopathic Arthritis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | |
Revision as of 20:31, 27 March 2018
Vasculitis |
|
---|
gsEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Differential Diagnosis
Abbreviations: ABG= Arterial blood gas, ANP= Atrial natriuretic peptide, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure.
References
- ↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
- ↑ Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
- ↑ Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
- ↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
- ↑ Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
- ↑ Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
- ↑ Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.
- ↑ Michet CJ, Matteson EL (2008). "Polymyalgia rheumatica". BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.
- ↑ Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.